Medicenna Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	15.75	24.84	16.98	33.6	20.54	30.38
Trading Asset Securities	-	-	-	-	-	10.01
Cash & Short-Term Investments	15.75	24.84	16.98	33.6	20.54	40.39
Cash Growth	-48.24%	46.26%	-49.45%	63.60%	-49.15%	7.12%
Other Receivables	1.26	2.7	1.16	0.86	1.31	0.41
Receivables	1.26	2.7	1.16	0.86	1.31	0.41
Prepaid Expenses	0.86	0.64	0.93	1.93	1.55	1.35
Total Current Assets	17.87	28.17	19.08	36.39	23.39	42.15
Property, Plant & Equipment	0.12	0.16	-	-	-	0.03
Other Intangible Assets	0.05	0.05	0.06	0.06	0.07	0.07
Total Assets	18.04	28.38	19.13	36.45	23.46	42.25
Accounts Payable	3.65	2.7	2.07	1.62	1.67	2.25
Accrued Expenses	0.75	1.69	0.79	2.18	0.95	1.83
Current Portion of Leases	0.06	0.05	-	-	-	0.03
Other Current Liabilities	-	-	-	3.16	-	-
Total Current Liabilities	4.46	4.44	2.86	6.96	2.62	4.11
Long-Term Leases	0.09	0.12	-	-	-	-
Other Long-Term Liabilities	3.25	4.73	11.08	-	-	-
Total Liabilities	7.8	9.29	13.94	6.96	2.62	4.11
Common Stock	126.24	116.3	100.92	100.92	83.67	79.59
Additional Paid-In Capital	12.01	11.22	10.7	9.49	7.93	6.68
Retained Earnings	-128.06	-118.25	-106.45	-80.98	-70.93	-48.36
Comprehensive Income & Other	0.05	9.83	0.02	0.06	0.17	0.23
Total Common Equity	10.24	19.1	5.19	29.49	20.84	38.15
Shareholders' Equity	10.24	19.1	5.19	29.49	20.84	38.15
Total Liabilities & Equity	18.04	28.38	19.13	36.45	23.46	42.25
Total Debt	0.15	0.17	-	-	-	0.03
Net Cash (Debt)	15.6	24.67	16.98	33.6	20.54	40.35
Net Cash Growth	-48.43%	45.27%	-49.45%	63.60%	-49.11%	7.22%
Net Cash Per Share	0.19	0.32	0.24	0.52	0.38	0.81
Filing Date Shares Outstanding	83.41	83.38	76.18	69.64	56.3	53.55
Total Common Shares Outstanding	83.41	78.22	69.64	69.64	55.65	53.55
Working Capital	13.41	23.74	16.21	29.43	20.77	38.04
Book Value Per Share	0.12	0.24	0.07	0.42	0.37	0.71
Tangible Book Value	10.19	19.04	5.13	29.43	20.77	38.07
Tangible Book Value Per Share	0.12	0.24	0.07	0.42	0.37	0.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.